GeneDx Holding
GeneDx is a company dedicated to providing personalized and actionable health insights that enhance diagnosis and treatment, ultimately improving health outcomes. Positioned at the intersection of diagnostics and data science, GeneDx combines decades of genomic expertise with the capability to interpret clinical data at scale. The company focuses on accelerating the application of genomic information and large-scale clinical data to establish precision medicine as a standard practice in healthcare. GeneDx leads the transformation of healthcare through its comprehensive exome and genome testing services, leveraging one of the largest rare disease data sets in the world. The business operates through two segments: GeneDx, which generates the majority of its revenue, and Legacy Sema4 diagnostics.
2 past transactions
Fabric Genomics (formerly Omicia)
Acquisition in 2025
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.
GeneDx (Old)
Acquisition in 2022
GeneDx, a division of BioReference Laboratories, is a global industry in genetics and genomics, providing testing to patients and families. GeneDx's mission is to provide personalized, actionable insights that improve health outcomes. They are at the crossroads of diagnostics and data science, combining decades of genomic expertise with an unrivaled ability to interpret clinical data at scale. The company's exome and genome testing are among the industry's best. They anticipate that it will become even more advanced in the future with the assistance of Centrellis, its cutting-edge health information platform. Centrellis, which is powered by millions of medical records, combines digital tools with artificial intelligence to ingest and synthesize clinical and genomic data.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.